Image

Community Health Worker-Led Postpartum Diabetes Screening

Community Health Worker-Led Postpartum Diabetes Screening

Recruiting
18 years and older
Female
Phase N/A

Powered by AI

Overview

Women who experience gestational diabetes are at high risk of developing type 2 diabetes mellitus in the postpartum period-especially in low- and middle-income countries like India where the burden of diabetes is high and disproportionately affects women- but few receive the World Health Organization-recommended postpartum diabetes screening test. The investigators propose a cluster randomized clinical trial to determine whether community health worker-administered, home-based testing increases uptake of postpartum diabetes screening in the urban slums of Pune, India. The proposed study will provide an acceptable and scalable model that can be used to improve postpartum diabetes screening in other low-income settings, thereby improving early detection of diabetes in women and preventing morbidity and mortality in this high-risk population.

Description

The purpose of the project is to determine the effectiveness of a community health worker (CHW)-delivered home based oral glucose tolerance test (OGTT) (home testing arm) versus referral for clinic-based screening (referral arm) and evaluate the implementation of the CHW-delivered programs.

Design and Project Type: This hybrid type II effectiveness- implementation cluster randomized trial aims to evaluate if CHWs can improve postpartum type 2 diabetes mellitus (T2DM) screening in the urban slums of Pune, India. Slum communities will be randomized in equal number to one of two study arms. Participants in both arms will receive CHW-delivered OGTT during pregnancy to screen for GDM. For women diagnosed with gestational diabetes mellitus (GDM), the investigators will evaluate two strategies to improve T2DM screening in the first year postpartum: CHW-delivered home based OGTT (home testing arm) versus referral for clinic-based screening (referral arm).

Description of Intervention: The intervention is postpartum screening for T2DM which involves oral intake of a glucose load and subsequent measurement of fasting and postprandial point of care blood glucose measurement.

Eligibility

Inclusion Criteria:

Pregnant Women:

  • Pregnant woman residing in one of pre-selected slum communities
  • 18 years or older
  • ≥ 24 weeks gestational age (as determined by self-reported last menstrual period or ultrasound)
  • Meet or exceed the threshold for GDM as determined by the CHW-delivered fasting OGTT
  • Agrees to study procedures, including in-person visits with the CHW postpartum if they are diagnosed with GDM

Community Health Workers:

  • 18 years or older
  • Willingness to participate in study procedures and recruit eligible pregnant women
  • Agreement with goals of the study
  • Resides in one of the study communities
  • Willing to participate in surveys and interviews
    Clinicians
  • 18 years or older
  • Diabetes or obstetrics physicians
  • In a patient-facing position for over 1 year

Ministry of Health Officials

  • 18 years or older
  • Employed by the Ministry of Health and Family Welfare, Maternal Health Division

Exclusion Criteria:

Pregnant Women:

  • Preexisting diabetes diagnosis prior to current pregnancy
  • Unable to tolerate food/ drink and remain fasting for 8 hoursUnwilling or unable to participate in study procedures
  • Unwilling or unable to provide informed consent

CHW, Clinicians, Ministry of Health Officials

  1. Unwilling or unable to participate in study procedures
  2. Unwilling or unable to provide informed consent

Study details
    Diabetes Mellitus
    Type 2
    Gestational Diabetes

NCT06209411

Weill Medical College of Cornell University

29 May 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.